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Abstract
Background: Although cryptococcosis mainly occurs in the central nervous system and lungs in
immunocompromised hosts, it can involve any body site or structure. Here we report the first case of primary
cryptococcosis of a lumbar vertebra without involvement of the central nervous system or lungs in a relatively
immunocompromised individual with rheumatoid arthritis and scleroderma.
Case presentation: A 40-year-old Chinese woman with rheumatoid arthritis diagnosed 1 year beforehand and with
a subsequent diagnosis of scleroderma was found to have an isolated cryptococcal infection of the fourth lumbar
vertebra. Her main complaints were severe low back and left leg pain. Cryptococcosis was diagnosed by CT-guided
needle biopsy and microbiological confirmation; however, serum cryptococcal antigen titer was negative. After 3
months of antifungal therapy with fluconazole the patient developed symptoms and signs of scleroderma, which
was confirmed on laboratory tests. After taking fluconazole for 6 months, the progressive destruction of the lumbar
vertebral body had halted and the size of an adjacent paravertebral mass had decreased substantially. On discharge
symptoms had resolved and at an annual follow-up there was no evidence of recurrence on the basis of
symptoms, signs or imaging investigations.
Conclusion: Although cryptococcosis of the lumbar vertebra is extremely rare, it should be considered in the
differential diagnosis for patients with lumbar vertebral masses to avoid missed diagnosis, misdiagnosis and
diagnostic delay. Early treatment with antifungals proved to be a satisfactory alternative to surgery in this relatively
immunocompromised patient. Any residual spinal instability can be treated later, once the infection has resolved.
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Background
Cryptococcus is an encapsulated fungus, which is wide-
spread in soil, rotten food and avian feces, especially
pigeon droppings [1]. Cryptococcosis caused by Crypto-
coccus neoformans var neoformans (CNVN) is most
likely to occur in immunocompromised hosts with cell-
mediated immune deficiency, and is generally viewed as
an opportunistic infectious disease [2-4], as there are
only a handful of case reports of established infection in
immunocompetent individuals [5,6]. Compared with
CNVN, Cryptococcus neoformans var gattii (CNVG) is
far more pathogenic and may infect immunocompetent
hosts, with a recent outbreak attracting public attention
[2,7]. CNVN and CNVG are increasingly thought to be
separate species [8]. It is believed that cryptococcosis
occurs upon inhalation of fungal propagules, which can
then spread to involve any body site or structure
through the blood or lymphatic system [3,6]. The central
nervous system (CNS) and lungs are the sites most com-
monly affected, while the skeletal system is involved in
5-10% of all disseminated Cryptococcus infections [9-12].
Here, we present a case of primary cryptococcosis invol-
ving the fourth lumbar vertebra without respiratory or* Correspondence: fengsq321@gmail.com†Equal contributors
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CNS involvement in a relatively immunocompromised in-
dividual with rheumatoid arthritis (RA) and scleroderma.
Case presentation
A 40-year-old Chinese woman presented to our hospital
complaining of low back pain that had been radiating to
the left leg for the past 2 months. She reported signifi-
cant weight loss of 7 kg, but no fever, chills, night
sweats, productive cough, headache, dizziness, nausea or
vomiting. One year earlier, she had been diagnosed with
RA and took oral non-steroidal anti-inflammatory drugs
in the first 3 months after the diagnosis. She had no his-
tory of tuberculosis or exposure to patients with tuber-
culosis. There was also no history of trauma to the back
or leg and no loss of bowel or bladder function. She
worked as a housewife and kept pigeons as pets, which
she fed daily.
On admission, the patient was in considerable discom-
fort. She was apyrexial. Cardiac and abdominal examina-
tions were normal, but on examination of the chest
inspiratory crepitus was detected in the lower right lung
base. Mild tenderness was found in the back around the
L4 area and movement of the spine was restricted.
Motor examination was normal, with normal power in
both legs, but tactile hypoesthesia of the right medial
femoral condyle was evident. The straight leg raising test
(SLRT) elicited pain at 70° on the left and was pain free
to 90° on the right. The right patellar reflex was normal,
but it was diminished on the left. There were no skin
nodules.
Magnetic resonance imaging (MRI) undertaken in
August 2010 demonstrated osteolytic lesions of the fourth
lumbar vertebral body (L4) that involved the left pedicle
and transverse process causing secondary spinal canal ste-
nosis at that level (Figure 1A, 1B). Moreover, a paravertebral
soft tissue mass was seen on both sides that was larger on
the left. The intervertebral discs were relatively preserved.
Single photon emission-computed tomography (SPECT)
showed increased uptake of technetium-99 m in the L4
vertebra (Figure 2). Routine blood tests revealed: a white
blood cell count of 6500/μL with 73.1% neutrophils (normal
range: 50-70%), 16.3% lymphocytes (normal: 20-40%),
1.1% eosinophils (normal: 0.5-5%), 0.2% basophils (nor-
mal: 0-1%) and 8.5% monocytes (normal: 3-8%); a
hemoglobin of 10.7 g/dL (normal: 11.0-16.0 g/dL) and a
platelet count of 368,000/μL (normal: 100,000-300,000/μL).
The erythrocyte sedimentation rate (ESR) was 22 mm/h
(normal: <20 mm/h) and the C-reactive protein (CRP) was
1.45 mg/dL (normal: <0.80 mg/dL). Tumor markers
(including alpha fetoprotein, carcinoembryonic antigen,
β2-microglobulin, ferroprotein and estradiol) were not
elevated, serum cryptococcal antigen and human immuno-
deficiency virus (HIV) antibodies were negative, but the tu-
berculin test (PPD skin test) was strongly positive.
A definitive diagnosis could not be established at this
stage. Fourteen days later we performed a CT-guided
needle aspiration biopsy and sent the material for cultur-
ing of bacteria, Mycobacteria and fungi, and also for
histopathological analysis. The latter revealed atypical
granulomas and large quantities of necrotic tissue with
scattered fungal organisms that were identified as
Cryptococcus by subsequent periodic acid-Schiff (PAS)
and Gomori’s methenamine silver (GMS) staining
(Figure 3). No malignant cells or epithelioid granulomas
were observed in this specimen. Microbial culture re-
vealed the growth of Cryptococcus sensitive to flucona-
zole (FLC) and flucytosine (5-FC), while Mycobacterium
tuberculosis culture was negative. Because of limited clin-
ical laboratory facilities, we could not conduct tests to
Figure 1 MRI of the lumbar vertebrae. (A) Transverse section
imaging of L4 showed the involvement of left pedicle and
transverse process, the paravertebral soft tissue mass and the spinal
canal stenosis. (B) Coronal section imaging of lumbar vertebrae
showed the osteolytic lesions of vertebral body at L4 level.
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distinguish CNVN from CNVG. Considering the anti-
microbial sensitivity test results and the side effects of
amphotericin B (AMB) and 5-FC, the patient was admin-
istered FLC 400 mg/d orally. The patient declined lum-
bar puncture that would have allowed examination of
cerebrospinal fluid.
After 3 months of FLC, the patient complained of pale
hands brought on by cold and a sensation of stiffness
under the skin in the face and distal extremities: these
areas felt indurated on palpation. Laboratory tests found:
an elevated γ-globulin (22.3%, normal range: 9.0-16.0%);
reduced albumin (57.9%, normal: 60-71%); an immuno-
globulin G of 1960 mg/dL (normal: 751-1560mg/mL);
a rheumatoid factor (RF) of 29 IU/mL (normal: <29 IU/mL);
a circulating immune complex (CIC) of 18 U/mL (nor-
mal: <13 U/mL) and an anti-citrulline-containing peptide
antibody (anti-CCP) of 20.9 U/mL (normal: <12 U/mL).
Also, extractable nuclear antigen anti-Smith surface anti-
gen antibody (ENA anti-SSA antibody), extractable nu-
clear antigen anti-U1 ribonuleoprotein antibody (ENA
anti-U1RNP antibody) and extractable nuclear antigen
anti-Scl-70 antibody (ENA anti-Scl-70 antibody) were all
positive and antinuclear antibody (ANA) titer was 1:400
(normal: <1:80). ESR had risen to 56 mm/h. As a result,
she was diagnosed with scleroderma and was treated with
total glucosides of paeony capsules for 16 days. Immuno-
suppressants were avoided because of concerns about on-
going disseminated infection.
During treatment with FLC, a plain X-ray of the lum-
bar spine was taken every 4 weeks (Figure 4). The X-ray
taken in December 2010 (Figure-4D) showed no signifi-
cant changes when compared with that of the previous
month (Figure-4C), suggesting that the destruction of
the lumbar vertebral body had abated. Meanwhile, the
MRI of November 2010 (Figure 5) showed that the size
of the paravertebral mass had decreased when compared
with the examination undertaken in August 2011 and
the spinal cord compression had been substantially alle-
viated. After 6 months of continuous oral FLC, her low
back and left leg pain had completely resolved. Mean-
while, tactile sensation over the right medial femoral
Figure 2 SPECT examinations. Increased uptake of technetium-99m in the area of L4 vertebrae.
Figure 3 Histopathological analysis of the paravertebral mass.
Atypical granulomas and massive necrotic tissue with scattered
fungal organisms (haematoxylin and eosine staining ×10).
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condyle, the SLRT of the left lower limb and the left pa-
tellar tendon reflex had recovered to normal. The pa-
tient was discharged having made a full recovery and
remained asymptomatic and with no radiological evi-
dence of relapse at 12-month follow-up.
Discussion
Cryptococcosis is rare disease in man and mainly affects
the immunocompromised [4]. It is extremely rare in
immunocompetent hosts, with an estimated incidence of
0.2 per million per year [13]. The CNS and lungs are
most commonly affected and involvement of the muscu-
loskeletal system is uncommon [9]. When bone is
affected, the rarest form is a primary infection without
involvement of other tissues [12].
On reviewing the English language literature reported
since 2000 we found 14 cases (Table 1), including ours,
of skeletal cryptococcosis [5,9,14-24]. Among these
cases, a total of 28 bony sites and joints were affected, of
which 11 were vertebrae, suggesting that vertebral in-
volvement is most common. This finding is consistent
with that of John Chleboun [12]. In 1977 he reported a
case series of 56 patients in which the vertebrae were
involved on 25 occasions out of a total of 117 bony sites
and joints. Of the 14 cases, the proportion of men to
women was 5:9 and the average age was 37.8 years
(range 19-84). Reports published since 2000 do not sug-
gest any predilection for age or gender [14], but this
might be a consequence of the small number of reports.
In all 14 of the more recent cases, 11 had been diag-
nosed with other diseases before cryptococcosis (Table 1).
Five of the 11 presented with a classical immunodefi-
ciency caused by HIV or immunosuppressant therapies
and the remainder had diagnoses consistent with relative
immunodeficiency such as sarcoidosis, lymphocytopenia,
tuberculosis, diabetes mellitus, renal transplantation, RA
and scleroderma [14,25-27]. Thus, complete and relative
immunocompromise appear to be the most important
risk factors for skeletal cryptococcosis, a view that is
consistent with previous reports [5,14,15].
Of the 13 cases reported in the literature, tests to dis-
tinguish CNVN from CNVG were not undertaken, des-
pite three cases occurring in the subtropics when CNVG
is traditionally viewed as a tropical and subtropical or-
ganism [28]. We did not attempt to differentiate be-
tween CNVN and CNVG. Cryptococcosis caused by
CNVG has never been reported in China, is generally
geographically restricted and the patient had no history
of travel to areas where CNVG is endemic. Finally, the
patient had a history of exposure to pigeon feces, which
has been described as a risk factor for CNVN infection
rather than CNVG [29,30]. It could be argued that it is
important to differentiate between the two organisms
because of differences in antifungal susceptibility and
the changing ecology and virulence of CNVG [31-33].
We recommend that they should be distinguished if pos-
sible to aid diagnosis, direct treatment and improve un-
derstanding of the disease.
In our case, the PPD skin test was strongly positive,
which suggests active infection with Mycobacteria. But
Figure 4 Plain X-ray of lumbar spine taken every 4 weeks during the treatment with fluconazole. (A and B) September and October.
(C and D) No significant changes were found between the imaging taken in November and December.
Figure 5 MRI of the lumbar vertebra taken in November 2010.
The decreased mass and the alleviated spinal cord compression.
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the history, clinical symptoms and signs, imaging exami-
nations, mycobacterial culture and histopathological
analysis did not support the diagnosis. Hence, lumbar
tuberculosis was excluded and we are not able to explain
the positive result.
Skeletal cryptococcosis is rare but treatable. Substan-
tial morbidity and mortality can arise from missed diag-
nosis, misdiagnosis or delay in diagnosis [34]. According
to a review of 11 cases of spinal fungal infections, the
average delay in diagnosis for 10 of the patients was 99
days and in the last case it took 9 years before the defini-
tive diagnosis was made [35]. One explanation is that
the history and radiologic findings resemble a variety of
other infectious and neoplastic disorders [36], another is
a lack of suspicion of cryptococcosis. Clinicians should
be alert to Cryptococcus infections and consider
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appropriate investigations that might contribute to a de-
finitive diagnosis. Cryptococcosis is usually diagnosed by
means of a combination of hematological tests, imaging
examinations, biopsies and microbial culture. The fol-
lowing should arouse suspicion of the diagnosis. First,
although serum cryptococcal antigen is an accurate indi-
cator of cryptococcal infection, it is not positive in all
cases [15,16,19,22], just like ours. Second, imaging exam-
inations may lack specificity, resulting in the need for
further examinations to differentiate the disease from
tuberculosis, neoplastic disorders and yaws, for example.
It is noteworthy that the imaging and surgical findings
of vertebral cryptococcosis can mimic spinal tubercu-
losis [5], so biopsies and microbial culture are essential
to make the definitive diagnosis.
Of the 14 cases reported since 2000, five were crypto-
coccosis of the spine (Table 1). All five received antifun-
gal chemotherapy even though there have been cases
cured with surgery alone [12]. One of the five was
treated with both surgery and antifungal drugs, but the
patient died soon afterwards. The cause of death was
attributed to the delay in diagnosis and hepatic failure
provoked by antitubercular treatment (ATT) [5]. Two of
the five cases received at least two types of antifungal
drug, while FLC was the sole agent in the other three.
Although skeletal cryptococcosis has been most fre-
quently treated with AMB and/or 5-FC [14,17,18], the
serious side effects of these drugs led us to prescribe
FLC 400 mg/d orally alone for this patient, in compli-
ance the guidelines of the Infectious Diseases Society of
America (IDSA) [37]. We were also guided by the sensi-
tivity of the organism grown on culture. Surgery was
not offered despite symptomatic spinal cord compres-
sion, as we perceived an increased risk of dissemina-
ting the infection and at present there are no
effective means of preventing this. Moreover, the
stress response to surgery might predispose to dis-
seminated infection. We recommend that antifungal
agents should be the first line treatment for relatively
immunocompromised hosts. Surgery should be con-
sidered only if antifungals prove to be ineffective. In
this case, surgery to improve the stability of the lum-
bar spine would be offered at a later date.
Conclusions
Cryptococcosis of the lumbar vertebra should be consid-
ered in the differential diagnosis of patients with lumbar
vertebral masses to avoid missed diagnosis, misdiagnosis
and diagnostic delay. The successful management of
cryptococcosis of the lumbar vertebra with fluconazole
alone shows that antimicrobials are a plausible early
treatment option that may obviate the need for surgery
in relatively immunocompromised patients.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
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